Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Schroeder (Borstel, Germany), L. Lunding (Borstel, Germany), C. Vock (Borstel, Germany), B. Schaub (Munich, Germany), U. Zissler (Munich, Germany), H. Fehrenbach (Borstel, Germany), M. Wegmann (Borstel, Germany). IL-37 ameliorates experimental asthma by inhibiting IL-1. 1647

Member's Comments

No comment yet.

Related content which might interest you: Exacerbation of experimental asthma depends on IL-6 but not on IL-23 or ROR?t Source: International Congress 2017 – Animal models of asthma and allergies Year: 2017 LSC - 2017 - IL-1R1 but not IL-18Rbeta or IL-18BP contribute to the beneficial effects of IL-37 on experimental asthma Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 Importin-7 knockdown reduces corticosteroid induced glucocorticoid receptor nuclear localisation and suppression of IL-1beta induced CXCL8 Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 Inhibition of LPS-induced cytokine/chemokine production from human lung macrophages by roflumilast is enabled by autocrine PGE2 Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics Year: 2010 Estrogen protects against airway inflammation via upregulation of SLPI and downregulation of IL-33 Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation Year: 2012 Role of proinflammatory cytokines IL-18 and IL-1β in bleomycin-induced lung injury in humans and mice Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis Year: 2009 IL-33 augments rhinovirus-induced type 2 immune responses in asthma via selective upregulation of one chain of the IL-33 receptor. Source: International Congress 2017 – "Alarming" immunological patterns in asthma Year: 2017 Caspase-1 induces upstream Th2-cytokines IL-33 and TSLP and eosinophilia at viral induced asthma exacerbations Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding Year: 2016 The GLP-1 receptor agonist Liraglutide attenuates intermittent hypoxia-induced pro-inflammatory macrophage polarization in primary macrophages Source: Virtual Congress 2021 – From pathophysiology to different diagnostic modalities in sleep disordered breathing Year: 2021 Statins suppress LPS-induced proinflammatory cytokine production from human bronchial epithelial cells Source: Annual Congress 2009 - Epithelial cell biology Year: 2009 Roflumilast inhibits chemokine release in animal models of COPD and asthma Source: Eur Respir J 2004; 24: Suppl. 48, 690s Year: 2004 Overexpression of CBP augments cigarette smoke-induced pro-inflammatory cytokine release in macrophages Source: Eur Respir J 2005; 26: Suppl. 49, 105s Year: 2005 Steroids induce a disequilibrium of secreted interleukin-1 receptor antagonist and interleukin-1? synthesis by human neutrophils Source: Eur Respir J 2011; 37: 406 Year: 2011 The treatment of bleomycin-induced lung injury with combination of antioxidants and interleukin-1 receptor antagonist (IL-1ra) Source: Eur Respir J 2002; 20: Suppl. 38, 488s Year: 2002 Blocking IL-4Ra with dupilumab prevents lung inflammation in a mouse asthma model Source: International Congress 2018 – Identification of therapeutic targets for asthma Year: 2018 Carbocisteine in vivo reduces circulating miR-21 and IL-8 in exacerbated COPD patients Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 IL-10 and IL-1ra mediates OVA-induced Th2 airway allergic response at short and long-term Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 Interleukin-17 enhances epithelial IL-6 production solely by stabilizing IL-6 mRNA, which is reversed by microRNA16 Source: Eur Respir J 2007; 30: Suppl. 51, 212s Year: 2007 Rhinovirus-induced cytokine production of circulating leukocytes is reduced in severe asthma Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD Year: 2020 TLR-4 downregulation in COPD impairs cytokine release from monocytes and Th1-lymphocytes in response to bacterial endotoxin Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009